5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study sought to explore the outcomes and prognostic factors of patients with small cell neuroendocrine carcinoma of the cervix (SCNEC) and to determine the effects of adjuvant treatment on survival in patients with FIGO stage I-II SCNEC after radical surgery.

          Related collections

          Author and article information

          Journal
          Gynecol Oncol
          Gynecologic oncology
          Elsevier BV
          1095-6859
          0090-8258
          December 2017
          : 147
          : 3
          Affiliations
          [1 ] Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
          [2 ] Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
          [3 ] Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: yanghj1@shca.org.cn.
          Article
          S0090-8258(17)31346-X
          10.1016/j.ygyno.2017.09.022
          28954697
          497b4532-6482-444d-b672-caad8d35c87d
          Copyright © 2017 Elsevier Inc. All rights reserved.
          History

          Small cell neuroendocrine carcinoma of the cervix,Adjuvant therapy,Radical surgery,EP chemotherapy,Disease recurrence

          Comments

          Comment on this article